Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 27 Show results per page	View Search Criteria \| Help With Results

Last Modified: 12/20/2006 First Published: 2/21/2003


1.		Phase III Randomized Study of Neoadjuvant Releasing Factor Agonist Therapy and Antiandrogen Therapy With or Without Docetaxel And Estramustine in Patients With Locally Advanced Prostate Cancer or With A High Risk of Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 80				Other				FRE-FNCLCC-GETUG-12/0203 EU-20238, NCT00055731


2.		Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				No age specified				Other				05-8-4 NCT00243646

Last Modified: 9/17/2008 First Published: 1/25/2006


3.		Phase III Randomized Study of Androgen Suppression (AS) and Radiotherapy (RT) Versus AS and RT Followed by Docetaxel and Prednisone in Patients With Localized, High-Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				RTOG-0521 RTOG-0521, NCT00288080

Last Modified: 9/18/2008 First Published: 5/11/2006


4.		Phase III Randomized Study of Zoledronate in Preventing Osteoporosis and Associated Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiotherapy and Luteinizing Hormone-Releasing Hormone Agonist Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				NCI				RTOG-0518 0518, RTOG-0518, NCT00329797


5.		PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 to 38				Other				1-whyte NCT00380406


6.		External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				2003-0819 NCT00388804

Last Modified: 9/19/2008 First Published: 1/25/2007


7.		Phase III Randomized Study of Radical Prostatectomy With Versus Without Neoadjuvant Chemohormonal Therapy Comprising Docetaxel and Androgen-Deprivation Therapy With Leuprolide Acetate or Goserelin in Patients With High-Risk, Clinically Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				CALGB-90203 CALGB-90203, NCT00430183


8.		A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				XRP6976J/3503 EudraCT#:2007-000323-17, NCT00514917

First Published: 10/3/2007


9.		Phase III Randomized Study of Immediate Versus Early Salvage Radiotherapy and Short- Versus Long-Term Androgen Deprivation Therapy in Patients Who Have Undergone Local Surgery for Nonmetastatic Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Any age				Other				MRC-RADICALS-PR10 MRC-RADICALS-PR10, ISRCTN40814031, EUDRACT-2006-000205-34, EU-20767, CAN-NCIC-CTG-PR13, NCT00541047

Last Modified: 5/20/2008 First Published: 3/31/2008


10.		Phase III Randomized Study of Androgen Suppression Therapy and Radiotherapy With Versus Without Docetaxel in Patients With High-Risk Localized Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				NCI				CAN-NCIC-PR12 PR12, NCT00651326

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute